Ashley Renee Baksh, PA
Physician Assistant · Freedom
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Offices
- 4
Offices
4 locations · Csi Medical Group · 104 clinicians in this group
Looking this up.
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Ashley Renee Baksh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G56868 · Current
Licensed to practise in California · since 1986 · expires 2028-01-31 · University of Missouri-Columbia School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$184,964
Medicare paid this office $184,964 for 711 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 476 | $44,396 | $61 |
| Destruction of skin growth, 1-14 growths | 254 | $24,887 | $79 |
| Destruction of precancer skin growth, 1 growth | 305 | $14,750 | $35 |
| Return visit (30+ min) | 121 | $13,877 | $88 |
| Biopsy of related skin growth, first growth | 166 | $10,130 | $58 |
See all 23 services
| Short return visit (20+ min) | 476 | $44,396 | $61 |
| Destruction of skin growth, 1-14 growths | 254 | $24,887 | $79 |
| Destruction of precancer skin growth, 1 growth | 305 | $14,750 | $35 |
| Return visit (30+ min) | 121 | $13,877 | $88 |
| Biopsy of related skin growth, first growth | 166 | $10,130 | $58 |
| New patient visit (30+ min) | 130 | $7,943 | $61 |
| Destruction of precancer skin growth, 15 or more growths | 46 | $6,726 | $129 |
| Destruction of precancer skin growth, 2-14 growths | 204 | $5,502 | $5 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 51 | $4,939 | $81 |
| Punch biopsy, first skin growth | 47 | $4,481 | $91 |
| Destruction of skin growth, 15 or more growths | 38 | $3,959 | $90 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 11 | $3,492 | $317 |
| New patient visit (45+ min) | 27 | $3,118 | $115 |
| Short return visit | 77 | $3,093 | $36 |
| Biopsy of related skin growth, each additional growth | 28 | $1,565 | $38 |
| Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 15 | $1,532 | $102 |
| Shaving of skin growth of body, arms, or legs, 0.5 cm or less | 24 | $1,483 | $57 |
| Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | 16 | $1,146 | $67 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | 11 | $997 | $91 |
| Injection into skin growth, 1-7 growths | 21 | $993 | $33 |
| Biopsy of ear | 12 | $709 | $47 |
| New patient visit (15+ min) | 15 | $540 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 22 | $30 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 33 | More than 81% of doctors who do this |
| Removal of skin lesions | 1808 | More than 97% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 182 | More than 89% of doctors who do this |
| Skin biopsy | 347 | More than 92% of doctors who do this |
Who their Medicare patients are
711 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 11% · Women 63% · Also on Medicaid 18% · Health risk score 1.06. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 68% · Diabetes 25% · Coronary heart disease 18% · Atrial fibrillation 18% · Chronic kidney disease 17% · Depression 15% · Cancer 13% · Heart failure 12% · COPD 9% · Dementia 5% · Stroke 4%.
The office billed $550,670, Medicare allowed $255,008 and paid $184,964; for 3,780 services of 80 kinds; $1,289 of it was for drugs given in the office and $183,675 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 711 | 3,780 | 74 | 1.06 | $550,670 | $184,964 |
| 2023 | 398 | 3,105 | 74 | 1.02 | $564,620 | $229,446 |
| 2022 | 163 | 906 | 75 | 1.00 | $110,600 | $46,091 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Short return visit (20+ min) | 237 | $27,846 | $65 |
| Destruction of skin growth, 1-14 growths | 127 | $14,587 | $90 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | 20 | $14,310 | $681 |
| Biopsy of related skin growth, first growth | 146 | $10,930 | $62 |
| Destruction of precancer skin growth, 1 growth | 153 | $9,632 | $39 |
| Destruction of precancer skin growth, 15 or more growths | 29 | $5,574 | $130 |
| New patient visit (30+ min) | 74 | $4,920 | $66 |
| Destruction of skin growth, 15 or more growths | 37 | $4,609 | $102 |
| Return visit (30+ min) | 36 | $4,268 | $93 |
| Destruction of precancer skin growth, 2-14 growths | 112 | $4,227 | $6 |
| Short return visit | 80 | $4,139 | $41 |
| Punch biopsy, first skin growth | 33 | $3,367 | $102 |
| Biopsy of related skin growth, each additional growth | 46 | $2,768 | $42 |
| New patient visit (45+ min) | 11 | $1,309 | $119 |
| Biopsy of ear | 14 | $913 | $65 |
| Injection into skin growth, 1-7 growths | 17 | $875 | $38 |
| New patient visit (15+ min) | 12 | $455 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 19 | $39 | None |
2022: 10 services
| Short return visit (20+ min) | 91 | $8,241 | $72 |
| Destruction of skin growth, 1-14 growths | 60 | $6,677 | $97 |
| Destruction of precancer skin growth, 1 growth | 77 | $3,556 | $40 |
| Short return visit | 61 | $3,135 | $45 |
| Biopsy of related skin growth, first growth | 38 | $2,972 | $74 |
| Destruction of precancer skin growth, 15 or more growths | 16 | $2,367 | $148 |
| Destruction of skin growth, 15 or more growths | 16 | $2,223 | $117 |
| Destruction of precancer skin growth, 2-14 growths | 58 | $2,097 | $6 |
| New patient visit (30+ min) | 13 | $1,118 | $86 |
| New patient visit (15+ min) | 16 | $901 | $56 |
Drugs they prescribed that Part D paid
$398,053
Pharmacies billed $398,053 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 928) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
838 generic and 90 brand-name prescriptions · $398,053 in drug cost · 51 antibiotic prescriptions to 38 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Otezla | 20 | $97,073 | $4,854 |
| Dupixent | 12 | $44,119 | $3,677 |
| Clobetasol Propionate | 81 | $5,038 | $62 |
| Fluorouracil | 48 | $3,759 | $78 |
| Ketoconazole | 118 | $2,255 | $19 |
See all 19 drugs
| Otezla | 20 | $97,073 | $4,854 |
| Dupixent | 12 | $44,119 | $3,677 |
| Clobetasol Propionate | 81 | $5,038 | $62 |
| Fluorouracil | 48 | $3,759 | $78 |
| Ketoconazole | 118 | $2,255 | $19 |
| Fluocinonide | 56 | $2,086 | $37 |
| Tacrolimus | 15 | $2,038 | $136 |
| Triamcinolone Acetonide | 99 | $1,126 | $11 |
| Imiquimod | 37 | $1,100 | $30 |
| Metronidazole | 27 | $1,046 | $39 |
| Mometasone Furoate | 24 | $771 | $32 |
| Doxycycline Hyclate | 45 | $683 | $15 |
| Clindamycin Phosphate | 12 | $576 | $48 |
| Hydrocortisone | 71 | $484 | $7 |
| Betamethasone Dipropionate | 14 | $403 | $29 |
| Mupirocin | 51 | $288 | $6 |
| Cimetidine | 12 | $242 | $20 |
| Fluconazole | 17 | $193 | $11 |
| Minoxidil | 24 | $111 | $5 |
Year by year
| 2024 | 928 | 349 | 0% (0) | 10% | $398,053 |
| 2023 | 414 | 151 | 0% (0) | 5% | $145,134 |
| 2022 | 235 | 97 | 0% (0) | None | $15,714 |
| 2021 | 445 | 120 | 0% (0) | 3% | $19,901 |
| 2020 | 950 | 171 | 3% (24) | 15% | $90,974 |
| 2019 | 37 | 23 | 41% (15) | None | $812 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Clobetasol Propionate | 44 | $2,846 | $65 |
| Fluorouracil | 26 | $2,437 | $94 |
| Tacrolimus | 15 | $1,929 | $129 |
| Metronidazole | 20 | $1,898 | $95 |
| Fluocinonide | 24 | $1,465 | $61 |
| Ketoconazole | 40 | $1,257 | $31 |
| Doxycycline Hyclate | 32 | $880 | $28 |
| Clindamycin Phosphate | 16 | $497 | $31 |
| Triamcinolone Acetonide | 61 | $416 | $7 |
| Imiquimod | 19 | $406 | $21 |
| Hydrocortisone | 21 | $345 | $16 |
| Mupirocin | 21 | $222 | $11 |
2022: 7 drugs
| Fluorouracil | 19 | $2,898 | $153 |
| Clobetasol Propionate | 17 | $2,193 | $129 |
| Metronidazole | 12 | $846 | $71 |
| Ketoconazole | 12 | $721 | $60 |
| Doxycycline Hyclate | 13 | $651 | $50 |
| Hydrocortisone | 28 | $421 | $15 |
| Triamcinolone Acetonide | 42 | $397 | $9 |
2021: 10 drugs
| Clobetasol Propionate | 29 | $3,777 | $130 |
| Fluocinonide | 21 | $1,783 | $85 |
| Ivermectin | 26 | $1,770 | $68 |
| Permethrin | 17 | $1,668 | $98 |
| Triamcinolone Acetonide | 114 | $1,654 | $15 |
| Metronidazole | 23 | $1,273 | $55 |
| Ketoconazole | 21 | $827 | $39 |
| Hydrocortisone | 44 | $608 | $14 |
| Hydroxyzine | 41 | $480 | $12 |
| Nystatin | 22 | $435 | $20 |
2020: 27 drugs
| Trulicity | 15 | $11,669 | $778 |
| Ezetimibe | 20 | $1,769 | $88 |
| Permethrin | 13 | $1,338 | $103 |
| Metronidazole | 13 | $1,257 | $97 |
| Rosuvastatin | 20 | $1,115 | $56 |
| Levothyroxine | 49 | $1,088 | $22 |
| Ketoconazole | 21 | $628 | $30 |
| Irbesartan | 24 | $609 | $25 |
| Triamcinolone Acetonide | 51 | $580 | $11 |
| Hydroxyzine | 17 | $548 | $32 |
| Atorvastatin | 19 | $532 | $28 |
| Clobetasol Propionate | 11 | $463 | $42 |
| Carvedilol | 20 | $300 | $15 |
| Fluocinonide | 12 | $293 | $24 |
| Omeprazole | 20 | $226 | $11 |
| Lisinopril | 24 | $210 | $9 |
| Hydrocortisone | 24 | $206 | $9 |
| Isosorbide Mononitrate Er | 12 | $187 | $16 |
| Losartan | 17 | $165 | $10 |
| Amlodipine Besylate | 20 | $133 | $7 |
| Metformin | 16 | $126 | $8 |
| Famotidine | 11 | $125 | $11 |
| Hydrochlorothiazide | 19 | $114 | $6 |
| Metoprolol | 11 | $109 | $10 |
| Clonidine | 12 | $84 | $7 |
| Simvastatin | 13 | $82 | $6 |
| Furosemide | 14 | $61 | $4 |
Money from drug and device companies
$4,111 in 2025
| 2025 | 20 | 193 | None | $4,111 |
| 2024 | 21 | 184 | None | $3,963 |
| 2023 | 19 | 149 | None | $3,323 |
| 2022 | 13 | 54 | None | $1,325 |
| 2021 | 2 | 9 | None | $239 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Regeneron Healthcare Solutions | Dupixent | $491 | 19 payments
|
| Abbvie | Skyrizi | $390 | 22 payments
|
| Genzyme | Dupixent | $390 | 10 payments
|
| Ucb | Bimzelx | $385 | 18 payments
|
| Incyte | Opzelura | $351 | 17 payments
|
| Novartis Pharmaceuticals | Cosentyx | $307 | 18 payments
|
See all 193 published payments
| Arcutis Biotherapeutics | Meals · 2025-12-17 | Zoryve | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-12-12 | Dupixent | $17 |
| Abbvie | Meals · 2025-12-11 | Rinvoq | $16 |
| Pfizer | Meals · 2025-12-11 | Cibinqo | $11 |
| Galderma Laboratories L.P. | Meals · 2025-12-11 | Nemluvio | $27 |
| Abbvie | Meals · 2025-12-10 | Skyrizi | $11 |
| Ucb | Meals · 2025-12-09 | Bimzelx | $16 |
| Pfizer | Meals · 2025-12-09 | Cibinqo | $17 |
| Novartis Pharmaceuticals | Meals · 2025-12-04 | Cosentyx | $19 |
| Incyte | Meals · 2025-12-04 | Opzelura | $26 |
| Galderma Laboratories L.P. | Meals · 2025-12-02 | Nemluvio | $27 |
| Abbvie | Meals · 2025-11-24 | Skyrizi | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-11-24 | Dupixent | $25 |
| ANI Pharmaceuticals | Meals · 2025-11-24 | Purified Cortrophin Gel | $31 |
| Incyte | Meals · 2025-11-20 | Opzelura | $7 |
| Incyte | Meals · 2025-11-20 | Opzelura | $15 |
| ANI Pharmaceuticals | Meals · 2025-11-20 | Purified Cortrophin Gel | $26 |
| Janssen Biotech | Meals · 2025-11-19 | Tremfya | $27 |
| Novartis Pharmaceuticals | Meals · 2025-11-19 | Cosentyx | $23 |
| Arcutis Biotherapeutics | Meals · 2025-11-18 | Zoryve | $24 |
| Genzyme | Meals · 2025-11-17 | Dupixent | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-11-14 | Dupixent | $17 |
| Arcutis Biotherapeutics | Meals · 2025-11-12 | Zoryve | $18 |
| LEO Pharma | Meals · 2025-11-11 | Anzupgo | $36 |
| LEO Pharma | Meals · 2025-11-11 | Anzupgo | $36 |
| Ucb | Meals · 2025-11-07 | Bimzelx | $13 |
| Pfizer | Meals · 2025-11-07 | Cibinqo | $14 |
| Incyte | Meals · 2025-11-05 | Opzelura | $29 |
| Novartis Pharmaceuticals | Meals · 2025-11-03 | Cosentyx | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-10-31 | Dupixent | $19 |
| Abbvie | Meals · 2025-10-30 | Rinvoq | $12 |
| Verrica Pharmaceuticals | Meals · 2025-10-29 | Ycanth | $25 |
| Pfizer | Meals · 2025-10-29 | Cibinqo | $21 |
| Abbvie | Meals · 2025-10-27 | Skyrizi | $23 |
| Janssen Biotech | Meals · 2025-10-23 | Tremfya | $2 |
| Janssen Biotech | Meals · 2025-10-23 | Tremfya | $7 |
| Janssen Biotech | Meals · 2025-10-23 | Tremfya | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-10-23 | Dupixent | $12 |
| Ucb | Meals · 2025-10-21 | Bimzelx | $14 |
| Galderma Laboratories L.P. | Meals · 2025-10-21 | Nemluvio | $35 |
| ANI Pharmaceuticals | Meals · 2025-10-21 | Purified Cortrophin Gel | $31 |
| Arcutis Biotherapeutics | Meals · 2025-10-21 | Zoryve | $9 |
| Genzyme | Meals · 2025-10-20 | Dupixent | $35 |
| Novartis Pharmaceuticals | Meals · 2025-10-16 | Cosentyx | $18 |
| Arcutis Biotherapeutics | Meals · 2025-10-15 | Zoryve | $20 |
| Galderma Laboratories L.P. | Meals · 2025-10-13 | Nemluvio | $5 |
| Lilly USA | Meals · 2025-10-09 | Taltz | $28 |
| Incyte | Meals · 2025-10-09 | Opzelura | $13 |
| Galderma Laboratories L.P. | Meals · 2025-10-09 | Nemluvio | $30 |
| Novartis Pharmaceuticals | Meals · 2025-10-08 | Rhapsido | $9 |
| Novartis Pharmaceuticals | Meals · 2025-10-07 | Xolair | $23 |
| ANI Pharmaceuticals | Meals · 2025-10-02 | Purified Cortrophin Gel | $30 |
| Sun Pharmaceutical Industries | Meals · 2025-10-02 | Leqselvi | $17 |
| Novartis Pharmaceuticals | Meals · 2025-10-01 | Cosentyx | $9 |
| Pfizer | Meals · 2025-10-01 | Cibinqo | $19 |
| Ucb | Meals · 2025-09-30 | Bimzelx | $22 |
| Lilly USA | Meals · 2025-09-25 | Taltz | $17 |
| Lilly USA | Meals · 2025-09-24 | Taltz | $32 |
| Abbvie | Meals · 2025-09-23 | Skyrizi | $21 |
| Ucb | Meals · 2025-09-23 | Bimzelx | $135 |
| Pfizer | Meals · 2025-09-23 | Cibinqo | $9 |
| ANI Pharmaceuticals | Meals · 2025-09-23 | Purified Cortrophin Gel | $29 |
| Novartis Pharmaceuticals | Meals · 2025-09-22 | Cosentyx | $12 |
| Regeneron Healthcare Solutions | Meals · 2025-09-19 | Dupixent | $13 |
| Galderma Laboratories L.P. | Meals · 2025-09-19 | Nemluvio | $24 |
| Arcutis Biotherapeutics | Meals · 2025-09-18 | Zoryve | $9 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-09-16 | Cabtreo | $15 |
| Incyte | Meals · 2025-09-16 | Opzelura | $29 |
| Novartis Pharmaceuticals | Meals · 2025-09-15 | Cosentyx | $19 |
| Abbvie | Meals · 2025-09-11 | Rinvoq | $30 |
| Ucb | Meals · 2025-09-09 | Bimzelx | $19 |
| Abbvie | Meals · 2025-09-05 | Skyrizi | $10 |
| Incyte | Meals · 2025-09-05 | Opzelura | $16 |
| Incyte | Meals · 2025-09-04 | Opzelura | $13 |
| Galderma Laboratories L.P. | Meals · 2025-08-29 | Nemluvio | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-08-22 | Dupixent | $14 |
| Incyte | Meals · 2025-08-21 | Opzelura | $11 |
| Abbvie | Meals · 2025-08-20 | Rinvoq | $10 |
| Ucb | Meals · 2025-08-19 | Bimzelx | $20 |
| Galderma Laboratories L.P. | Meals · 2025-08-19 | Nemluvio | $31 |
| Arcutis Biotherapeutics | Meals · 2025-08-19 | Zoryve | $14 |
| Pfizer | Meals · 2025-08-14 | Cibinqo | $20 |
| Abbvie | Meals · 2025-08-12 | Skyrizi | $21 |
| Novartis Pharmaceuticals | Meals · 2025-08-07 | Cosentyx | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-08-05 | Dupixent | $22 |
| Abbvie | Meals · 2025-08-04 | Skyrizi | $13 |
| Regeneron Healthcare Solutions | Education · 2025-08-04 | Dupixent | $96 |
| Janssen Biotech | Meals · 2025-08-01 | Tremfya | $11 |
| Pfizer | Meals · 2025-07-29 | Cibinqo | $25 |
| Genzyme | Meals · 2025-07-28 | Dupixent | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-07-25 | Dupixent | $23 |
| Sun Pharmaceutical Industries | Meals · 2025-07-22 | Winlevi | $22 |
| Arcutis Biotherapeutics | Meals · 2025-07-22 | Zoryve | $12 |
| Abbvie | Meals · 2025-07-21 | Rinvoq | $18 |
| Janssen Biotech | Meals · 2025-07-17 | Tremfya | $6 |
| Janssen Biotech | Meals · 2025-07-17 | Tremfya | $7 |
| Abbvie | Meals · 2025-07-15 | Skyrizi | $9 |
| Novartis Pharmaceuticals | Meals · 2025-07-14 | Xolair | $26 |
| Abbvie | Meals · 2025-07-11 | Skyrizi | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-07-09 | Dupixent | $10 |
| Ucb | Meals · 2025-07-08 | Bimzelx | $18 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Cosentyx | $26 |
| Genzyme | Meals · 2025-06-30 | Dupixent | $37 |
| Janssen Biotech | Education · 2025-06-25 | Tremfya | $99 |
| Arcutis Biotherapeutics | Meals · 2025-06-23 | Zoryve | $21 |
| Janssen Biotech | Meals · 2025-06-20 | Tremfya | $3 |
| Janssen Biotech | Meals · 2025-06-20 | Tremfya | $14 |
| Janssen Biotech | Meals · 2025-06-18 | Tremfya | $3 |
| Lilly USA | Meals · 2025-06-17 | Taltz | $18 |
| Ucb | Meals · 2025-06-17 | Bimzelx | $13 |
| Abbvie | Education · 2025-06-11 | Skyrizi | $10 |
| Incyte | Meals · 2025-06-11 | Opzelura | $8 |
| Sun Pharmaceutical Industries | Meals · 2025-06-11 | Winlevi | $22 |
| Pfizer | Meals · 2025-06-10 | Cibinqo | $17 |
| Janssen Biotech | Meals · 2025-06-04 | Tremfya | $14 |
| Pfizer | Meals · 2025-06-03 | Cibinqo | $30 |
| Incyte | Meals · 2025-05-29 | Opzelura | $15 |
| Lilly USA | Meals · 2025-05-28 | Ebglyss | $12 |
| Galderma Laboratories L.P. | Meals · 2025-05-22 | Nemluvio | $7 |
| Novartis Pharmaceuticals | Meals · 2025-05-15 | Cosentyx | $8 |
| Janssen Biotech | Meals · 2025-05-14 | Tremfya | $13 |
| Janssen Biotech | Meals · 2025-05-13 | Tremfya | $22 |
| Pfizer | Meals · 2025-05-12 | Cibinqo | $17 |
| Regeneron Healthcare Solutions | Meals · 2025-05-02 | Dupixent | $117 |
| Novartis Pharmaceuticals | Meals · 2025-05-01 | Cosentyx | $13 |
| Incyte | Meals · 2025-05-01 | Opzelura | $11 |
| Genzyme | Meals · 2025-05-01 | Dupixent | $125 |
| Ucb | Meals · 2025-04-29 | Bimzelx | $9 |
| Pfizer | Meals · 2025-04-29 | Cibinqo | $30 |
| Arcutis Biotherapeutics | Meals · 2025-04-29 | Zoryve | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-04-28 | Libtayo | $9 |
| Abbvie | Meals · 2025-04-22 | Skyrizi | $9 |
| Genzyme | Meals · 2025-04-21 | Dupixent | $25 |
| Galderma Laboratories L.P. | Meals · 2025-04-18 | Nemluvio | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-04-17 | Dupixent | $12 |
| Arcutis Biotherapeutics | Meals · 2025-04-16 | Zoryve | $18 |
| Ucb | Meals · 2025-04-15 | Bimzelx | $15 |
| Pfizer | Meals · 2025-04-15 | Cibinqo | $10 |
| Botanix SB | Meals · 2025-04-15 | Sofdra | $23 |
| Janssen Biotech | Meals · 2025-04-09 | Tremfya | $11 |
| Galderma Laboratories L.P. | Meals · 2025-04-02 | Nemluvio | $12 |
| Abbvie | Meals · 2025-04-01 | Rinvoq | $25 |
| Ucb | Meals · 2025-04-01 | Bimzelx | $12 |
| Organon | Meals · 2025-03-27 | Vtama | $14 |
| Sun Pharmaceutical Industries | Meals · 2025-03-27 | Winlevi | $27 |
| Pfizer | Meals · 2025-03-25 | Cibinqo | $21 |
| Genzyme | Meals · 2025-03-25 | Dupixent | $27 |
| Janssen Biotech | Meals · 2025-03-24 | Tremfya | $12 |
| Abbvie | Meals · 2025-03-24 | Rinvoq | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-03-21 | Dupixent | $16 |
| Ucb | Meals · 2025-03-21 | Bimzelx | $2 |
| Incyte | Meals · 2025-03-21 | Opzelura | $13 |
| Regeneron Healthcare Solutions | Education · 2025-03-20 | Dupixent | $7 |
| Ucb | Meals · 2025-03-20 | Bimzelx | $8 |
| Abbvie | Meals · 2025-03-18 | Skyrizi | $19 |
| Amgen | Meals · 2025-03-18 | Otezla | $26 |
| Pfizer | Meals · 2025-03-18 | Cibinqo | $10 |
| Lilly USA | Meals · 2025-03-17 | Taltz | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-03-14 | Libtayo | $22 |
| Novartis Pharmaceuticals | Meals · 2025-03-13 | Cosentyx | $7 |
| Lilly USA | Meals · 2025-03-11 | Taltz | $34 |
| Ucb | Meals · 2025-03-11 | Bimzelx | $16 |
| Galderma Laboratories L.P. | Meals · 2025-03-11 | Nemluvio | $23 |
| Botanix SB | Meals · 2025-03-07 | Sofdra | $18 |
| Abbvie | Meals · 2025-03-04 | Skyrizi | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-03-04 | Dupixent | $14 |
| Incyte | Meals · 2025-03-04 | Opzelura | $24 |
| Arcutis Biotherapeutics | Meals · 2025-03-03 | Zoryve | $21 |
| Novartis Pharmaceuticals | Meals · 2025-02-27 | Cosentyx | $31 |
| Genzyme | Meals · 2025-02-25 | Dupixent | $35 |
| Abbvie | Meals · 2025-02-21 | Skyrizi | $11 |
| Ucb | Meals · 2025-02-21 | Bimzelx | $34 |
| Novartis Pharmaceuticals | Meals · 2025-02-18 | Xolair | $19 |
| Genzyme | Meals · 2025-02-13 | Dupixent | $23 |
| Ucb | Meals · 2025-02-11 | Bimzelx | $8 |
| Pfizer | Meals · 2025-02-11 | Cibinqo | $9 |
| Organon | Meals · 2025-02-11 | Vtama | $9 |
| Genzyme | Meals · 2025-02-10 | Dupixent | $31 |
| Galderma Laboratories L.P. | Meals · 2025-02-07 | Nemluvio | $13 |
| Novartis Pharmaceuticals | Meals · 2025-02-06 | Cosentyx | $11 |
| Biofrontera | Meals · 2025-02-05 | None | $19 |
| Arcutis Biotherapeutics | Meals · 2025-01-30 | Zoryve | $19 |
| Arcutis Biotherapeutics | Meals · 2025-01-29 | Zoryve | $80 |
| Galderma Laboratories L.P. | Meals · 2025-01-28 | Nemluvio | $20 |
| Janssen Biotech | Meals · 2025-01-23 | Tremfya | $17 |
| Arcutis Biotherapeutics | Meals · 2025-01-22 | Zoryve | $11 |
| Abbvie | Meals · 2025-01-21 | Skyrizi | $32 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-01-21 | Siliq | $15 |
| Incyte | Meals · 2025-01-21 | Opzelura | $12 |
| Incyte | Meals · 2025-01-21 | Opzelura | $98 |
| Incyte | Meals · 2025-01-09 | Opzelura | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-01-07 | Dupixent | $26 |
| Ucb | Meals · 2025-01-06 | Bimzelx | $11 |
See earlier years (2024, 2023, 2022, 2021)
2024: $3,963
| Regeneron Healthcare Solutions | Dupixent | $688 | 27 payments
|
| Abbvie | Skyrizi | $421 | 20 payments
|
| Janssen Biotech | Tremfya | $420 | 17 payments
|
| Genzyme | Dupixent | $302 | 11 payments
|
| Pfizer | Cibinqo | $286 | 10 payments
|
| Incyte | Opzelura | $285 | 21 payments
|
| Novartis Pharmaceuticals | Cosentyx | $278 | 18 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $239 | 11 payments
|
| Lilly USA | Taltz | $209 | 9 payments
|
| Sun Pharmaceutical Industries | Ilumya | $202 | 8 payments
|
| Arcutis Biotherapeutics | Zoryve | $144 | 9 payments
|
| Dermavant Sciences | Vtama | $138 | 7 payments
|
| Galderma Laboratories L.P. | None | $100 | 4 payments
|
| Ortho Dermatologics a division of Bausch Health US | Siliq | $56 | 3 payments
|
| Amgen | Otezla | $51 | 2 payments
|
| LEO Pharma | Adbry | $44 | 2 payments
|
| Ucb | Bimzelx | $28 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $23 | 1 payment
|
| MIMEDX Group | None | $21 | 1 payment
|
| Teva Pharmaceuticals USA | Simlandi | $16 | 1 payment
|
| Biofrontera | Ameluz | $10 | 1 payment
|
2023: $3,323
| Janssen Biotech | Tremfya | $444 | 19 payments
|
| Incyte | Opzelura | $417 | 20 payments
|
| Genzyme | Dupixent | $402 | 15 payments
|
| Dermavant Sciences | Vtama | $378 | 15 payments
|
| Abbvie | Skyrizi | $274 | 15 payments
|
| Arcutis Biotherapeutics | None | $207 | 8 payments
|
| Novartis Pharmaceuticals | Cosentyx | $197 | 15 payments
|
| Regeneron Healthcare Solutions | Dupixent | $197 | 14 payments
|
| Amgen | Otezla | $174 | 4 payments
|
| Lilly USA | Olumiant | $165 | 4 payments
|
| Sun Pharmaceutical Industries | Winlevi | $142 | 8 payments
|
| Sanofi-Aventis U.S. | Dupixent | $100 | 1 payment
|
| LEO Pharma | Adbry | $64 | 3 payments
|
| Ucb | Cimzia | $63 | 3 payments
|
| Genentech USA | Xolair | $26 | 1 payment
|
| Galderma Laboratories L.P. | None | $22 | 1 payment
|
| Journey Medical | None | $19 | 1 payment
|
| STRATA Skin Sciences | Xtrac | $16 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $15 | 1 payment
|
2022: $1,325
| Sun Pharmaceutical Industries | Winlevi | $400 | 10 payments
|
| Regeneron Healthcare Solutions | Dupixent | $224 | 13 payments
|
| LEO Pharma | Adbry | $200 | 5 payments
|
| Genzyme | Dupixent | $131 | 7 payments
|
| Novartis Pharmaceuticals | Cosentyx | $73 | 4 payments
|
| Janssen Biotech | Tremfya | $61 | 3 payments
|
| Abbvie | Humira | $55 | 3 payments
|
| Galderma Laboratories L.P. | Twyneo | $47 | 3 payments
|
| Incyte | Opzelura | $40 | 2 payments
|
| Journey Medical | Qbrexza | $24 | 1 payment
|
| Dermavant Sciences | Vtama | $24 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $23 | 1 payment
|
| Lilly USA | Taltz | $23 | 1 payment
|
2021: $239
| Incyte | Opzelura | $125 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $114 | 8 payments
|
Professional record
- NPI
- 1598273328
- Licence
- CA 56868California G56868: Current · expires 2028-01-31
- Group
- Csi Medical Group
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 6399 San Ignacio Ave Ste 120, San Jose, CA, 95119
- NPI first listed
- 2018-01-15
- NPI last updated
- 2023-03-07
- NPI record certified
- 2023-02-15
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 204 Green Valley Rd, Freedom, CA, 95019